PDCD1 and neoplasm: In deterring the immune surveillance of tumor cells by PD-1-PD-L1-mediated signaling checkpoints, CAFs have been reported to interact with the TME’s immune landscape [8] and thus form the pro-tumorigenic support system of a progressive tumor.